cells were maintained in Dulbecco's modified Eagle's medium without phenol red, supplemented with fetal bovine serum (5%) treated with dextran-coated charcoal. The cells were transfected at 40 to 50% confluency in 10-cm petri dishes with a total of 20 g of the indicated plasmids using calcium phosphate. All assays were done in the presence of 3 g of pCH110 (Pharmacia), a ␤-galactosidase expression vector, as an internal control to normalize for variations in transfection efficiency. Cognate ligands were added to the medium 1 hour after transfection and at each exchange of medium. After 24-hour incubation with the calcium phosphate-precipitated DNA, the cells were washed with fresh medium and incubated for an additional 24 hours. Cell extracts were prepared by freezing and thawing and were assayed for CAT activity after normalization for ␤-galactosidase activity as described (9). 11. The mammalian expression vector pcDNA3 (Invitrogen) was used for the expressions of Smad and SRC-1 proteins. Constitutively active and catalytically inactive forms of T␤R-I, BMPR-IA, and BMPR-IB were as described (12) Masuyama et al., Mol. Endocrinol. 11, 1507 C. H. Jin et al., ibid. 10, 945 (1996). 26. Cells were harvested and washed twice with ice-cold phosphate-buffered saline. Centrifuged cells were resuspended in 4 ml ice-cold lysis buffer [10 mM Tris-HCl (pH 7.4), 10 mM NaCl, 3 mM MgCl 2 , 0.5% (v/v) NP-40] and incubated on ice for 15 min, then centrifuged again for 5 min at 500g. The sedimented nuclear fraction was resuspended in TNE buffer [10 mM tris-HCl (pH 7.8), 1% NP-40, 0.15 M NaCl, 1 mM EDTA], incubated for 30 min on ice, and centrifuged. The supernatant was used as nuclear extract for the experiments.
; C. H. Jin et al., ibid. 10, 945 (1996) . 26. Cells were harvested and washed twice with ice-cold phosphate-buffered saline. Centrifuged cells were resuspended in 4 ml ice-cold lysis buffer [10 mM , 10 mM NaCl, 3 mM MgCl 2 , 0.5% (v/v) and incubated on ice for 15 min, then centrifuged again for 5 min at 500g. The sedimented nuclear fraction was resuspended in TNE buffer [10 mM tris-HCl (pH 7.8), 1% NP-40, 0.15 M NaCl, 1 mM EDTA], incubated for 30 min on ice, and centrifuged. The supernatant was used as nuclear extract for the experiments. 27. T. Spencer et al., Nature 389, 194 (1997) ; T. Yao et al., Proc. Natl. Acad. Sci. U.S.A. 93, 10626 (1997) .
28. J. J. Voegel et al., EMBO J. 17, 507 (1998 Although broken chromosomes can induce apoptosis, natural chromosome ends (telomeres) do not trigger this response. It is shown that this suppression of apoptosis involves the telomeric-repeat binding factor 2 (TRF2). Inhibition of TRF2 resulted in apoptosis in a subset of mammalian cell types. The response was mediated by p53 and the ATM (ataxia telangiectasia mutated) kinase, consistent with activation of a DNA damage checkpoint. Apoptosis was not due to rupture of dicentric chromosomes formed by end-to-end fusion, indicating that telomeres lacking TRF2 directly signal apoptosis, possibly because they resemble damaged DNA. Thus, in some cells, telomere shortening may signal cell death rather than senescence.
Mammalian telomeres consist of several kilobases of tandem TTAGGG repeats bound by the related telomere-specific proteins, TRF1 and TRF2 (1) . TRF1 regulates telomere length (2) and TRF2 maintains telomere integrity (3) . Inhibition of TRF2 results in loss of the G-strand overhangs from telomere termini and induces covalent fusion of chromosome ends (3, 4) .
To investigate the cellular consequences of telomere malfunction, we used adenoviral vectors to overexpress intact and truncated versions of TRF1 and TRF2 ( Fig. 1) (5) . These vectors encoded full-length TRF1 (AdTRF1); a dominant negative version of TRF1 lacking the Myb DNA binding domain (AdTRF1 ⌬M ); fulllength TRF2 (AdTRF2); an NH 2 -terminal deletion of TRF2 lacking the TRF2-specific basic ). Transformed and primary cells were infected efficiently, resulting in overexpression of the different TRF proteins at approximately the same levels (6).
Indirect immunofluorescence analysis (2, 3, 7) indicated that TRFs retaining the Myb domain localized to telomeres, as deduced from their characteristic punctate staining pattern in interphase nuclei ( Fig. 1 ) (6). In contrast, TRFs lacking the Myb domain did not accumulate at telomeres but displayed a dispersed nuclear staining pattern. Expression of AdTRF1
⌬M reduced the TRF1-specific TTAGGG repeat binding activity in cell extracts (8, 9), implying that this allele has the expected dominant interfering effect on the DNA binding activity of endogenous TRF1. The dominant negative effect of AdTRF2 ⌬B⌬M was documented based on displacement of the endogenous TRF2 protein from the telomeres and its ability to induce chromosome end fusions ( Fig. 1 and Table 1 
) (3).
AdTRF2 ⌬B⌬M resulted in a rapid induction of apoptosis in infected HeLa cells, as assessed by TUNEL labeling, Annexin-V staining, and the appearance of cells with a sub-G 1 DNA content in fluorescence activated cell sorting (FACS) analysis (10) (Fig. 2, A 
and B). HeLa cells transfected with an unrelated TRF2
⌬B⌬M expression construct lacking adenoviral sequences had the same response, demonstrating that apoptosis did not require adenoviral gene products. None of the other TRF alleles affected cell viability or growth in the short term, although a minor G 2 accumulation phenotype occurred in HeLa cells expressing full-length TRF1 and TRF2 ( Fig. 2B ) (11). The absence of apoptosis with AdTRF2 and AdTRF2 ⌬B suggested that AdTRF2 ⌬B⌬M induced apoptosis by reducing the amount of TRF2 bound to telomeres.
In contrast to HeLa cells, the HDF cell strain IMR-90 and the fibrosarcoma cell line HT-1080 did not undergo apoptosis after inhibition of TRF2 ( Fig. 2A) (3) . To explore the cell-type dependence of the apoptotic response, we infected several immortalized human cell lines and primary human cell strains with AdTRF2 
ry CD4
ϩ T cells ( Table 1 ). Cells that failed to undergo apoptosis in response to AdTRF2 ⌬B⌬M either lacked an apoptotic response to DNA damage (12) or were deficient for p53 function (13). Although HeLa cells are partially compromised for p53 function because they express human papilloma virus-16 E6 tumor antigen, which targets p53 for degradation, they do contain a fully functional p53 pathway (14). To investigate this pathway, we examined protein levels of p53 and its downstream target Bax in HeLa cells expressing the five different TRF alleles (15). p53 levels rose only in response to AdTRF2
⌬B⌬M and there was a concomitant increase in the expression of Bax (Fig.  2C ), indicating that p53 is activated as a transcription factor. Induction of p53 and Bax was also observed in cells not undergoing apoptosis.
The role of p53 was confirmed using mouse embryo fibroblasts (MEFs) from genetically altered mice. The dimerization domains of human TRF2 and mouse Trf2 are nearly identical (1) , suggesting that the mouse protein would be inhibited by AdTRF2. Indeed, wild-type MEFs infected with AdTRF2
⌬B⌬M lost the punctate nuclear pattern typical of Trf2 engaged on telomeres and showed chromosome end fusions ( -/-MEFs, since the cells displayed a high rate of anaphase bridge formation. These data establish a requirement for p53 function in the telomere-mediated apoptotic pathway. p53 can be phosphorylated by the ATM kinase, the product of the gene that is mutated in patients with ataxia-telangiectasia (A-T) (22). ATM is thought to function upstream of p53 in a DNA damage response pathway because A-T cells show diminished induction of p53 and reduced ability to arrest in G 1 after ionizing radiation (23). To explore the possibility that ATM also functions in the telomeredirected apoptotic response documented here, we analyzed the effect of AdTRF2
⌬B⌬M on the viability of human B cell lines from A-T patients and normal donors. Normal B cell lines rapidly underwent apoptosis, whereas B cells from A-T patients did not show this response (Fig. 3B and Table 2 ). In addition, paralleling their response to ␥-irradiation, B cells from A-T patients showed no evidence of p53 induction or up-regulation of the p53 target p21 after infection with AdTRF2 ⌬B⌬M (Fig. 3C) . Thus, similar to the signaling pathway activated by double-stranded breaks, the induction of apoptosis by telomere malfunction requires ATM, most likely as an upstream activator of p53.
Two types of events might be responsible for the activation of the ATM/p53-dependent apoptotic pathway. Because loss of TRF2 function induces covalent fusion of telomeres (3, 4) , mitotic rupture of dicentric chromosomes will generate DNA breaks that can activate a DNA damage response. However, a signal could also emanate directly from the chromosome ends, if telomeres lacking TRF2 resemble damaged DNA. To distinguish between these possibilities, we determined whether progression through mitosis is required for the AdTRF2 ⌬B⌬M -induced apoptosis. Primary human peripheral T cells were harvested in a quiescent state, stimulated to proliferate in the presence of bromodeoxyuridine (BrdU), and infected with AdTRF2 ⌬B⌬M and AdTRF2 prior to entry into S phase (24). Cells were simultaneously examined for BrdU incorporation and apoptosis 24 hours later (Fig. 3D) . Although adenovirus infection inhibited T cell proliferation slightly, a substantial fraction of the cells progressed through S phase and incorporated BrdU. As expected, AdTRF2
⌬B⌬M , but not AdTRF2, induced apoptosis in primary T cells. While some cells showed dual labeling for both BrdU and TUNEL, a substantial proportion (ϳ80%) of the apoptotic cells in the AdTRF2
⌬B⌬M -infected cultures did not contain detectable amounts of BrdU (Fig.  3D) . Thus, a subset of the AdTRF2 ⌬B⌬M -infected cells entered apoptosis before progressing through S-phase, and hence before undergoing mitosis. This interpretation is corroborated by the drop in BrdU-positive cells in AdTRF2 ⌬B⌬M -infected T cells (Fig.  3D) (24) . Based on these data, we conclude that in primary human T cells, inhibition of TRF2 function can induce apoptosis independent of the damage resulting from broken dicentric chromosomes.
Collectively, these data reveal a previously unrecognized function of mammalian telomeres: their ability to prevent the induction of apoptosis by chromosome ends. We considered the possibility that inhibition of TRF2 might result in sudden loss of telomeric DNA, leaving uncapped chromosome ends that could activate a DNA damage checkpoint. However, HeLa and IMR-90 cells infected with AdTRF2 ⌬B⌬M showed no loss of TTAGGG repeat DNA detectable by standard genomic blotting. Thus, binding of TRF2 to the TTAGGG repeats is apparently required to "mask" chromosome ends from a response pathway that can lead to cell death. The exact nature of the apoptotic signal from the unmasked telomeres remains to be established. The involvement of ATM suggests that inappropriately exposed telomeric DNA might resemble a doublestranded break, which is the predominant initiating signal for ATM-mediated p53 activation [reviewed in (25) ]. Cells expressing TRF2
⌬B⌬M rapidly lose the 3Ј overhang of telomeric TTAGGG repeats that protrudes from human telomeres (3), so conceivably, this unique feature of telomeres may be a criterion by which random double-stranded breaks are distinguished from natural chromosome ends. However, we cannot exclude the existence of an ATM/p53-dependent telomeric checkpoint that directly senses the altered status of the telomeric complex in TRF2
⌬B⌬M -expressing cells. Compromised telomere function leads to deregulation of telomere length, fusions of chromosome ends, and senescence (2, 3, 26) . Our data indicate that at least in some mammalian cell types, telomere malfunction can also induce apoptosis, a suggestion consistent with the increased rate of apoptosis in mice with critically shortened telomeres (27) . Thus, disintegration of the telomeric complex as a consequence of telomere erosion in the human soma may cause apoptosis of some cells (such as T cells) and senescence of others (such as fibroblasts). Since telomeres also shorten during tumorigenesis (28), induction of the apoptotic pathway described here may provide an additional selection for malignant cells that are deficient in p53 function. and the expression of the TRF alleles are given at the Science Web site (www.sciencemag.org/feature/data/ 986472.shl). Plaque-purified viruses were expanded on 293 cells, purified by CsCl banding, and stored at -20°C in 50% glycerol. For infections, 2 ϫ 10 5 cells were mixed with virus in 1.4 ml of media and plated into six-well dishes. HeLa, Saos-2, SW 626, and HT-1080 were infected with 12 plaque-forming units (pfu) per cell; IMR-90, WI-38, HS68, and MRC-5 with 36 pfu/cell; MEFs with 100 pfu/cell; and B and T cells with 360 pfu/cell. We have found that long-term (Ͼ4 days) adenovirus infection inhibits cell growth and alters the expression of cell-cycle markers. For this reason, data were collected within 96 hours after infection. The adenoviral growth inhibition prevented the analysis of a possible senescence response to TRF proteins. 7. We used the M2 monoclonal antibody (Kodak) to detect the FLAG epitope, the 9E10 monoclonal antibody to detect the myc tag, antibody #371 to detect TRF1 and antibody #508 to detect TRF2 by indirect immunofluorescence (IF) (2, 3) . Rabbit antibodies (#371 and #508) were detected with tetramethyl rhodamine isothiocyanate ( TRITC)-conjugated donkey antibodies to rabbit immunoglobulin (IgG), and mouse antibodies (M2, 9E10) were detected with fluorescein isothiocyanate (FITC)-conjugated donkey antibodies to mouse IgG (Jackson). The secondary antibodies did not crossreact. DNA was stained with 4,6-diamino-2-phenylindole (DAPI) (0.2 g/ml). 8. A. Bianchi et al., EMBO J. 16, 1785 . 9. TRF1 gel-shift assays (8) were performed with 2 g cellular protein extracted in buffer containing 0.1% NP-40 and 0.4 M KCl (2) Shen et al., Proc. Natl. Acad. Sci. U.S.A. 94, 13618 (1997) . The modest G 2 accumulation observed in HeLa cells infected with AdTRF1 and AdTRF2 appears to be a HeLa-specific phenotype because it does not occur in HT-1080 (2), WI-38, and IMR-90. 12. A. Di Leonardo et al., Genes Dev. 8, 2540 (1994) ; J.
Yeargin and M. Haas, Curr. Biol. 5, 423 (1995) . 13. X. Chen, L. J. Ko, L. Jayaraman, C. Prives, Genes Dev. 10, 2438 Dev. 10, , (1996 T. Strobel et al., Proc. Natl. Acad. Sci. U.S.A. 93, 14094 (1996) . 14. M. Scheffner et al., Cell 63, 1129 ⌬B⌬M , this punctate pattern was lost or reduced (3). The dominant negative activity of AdTRF2 ⌬B⌬M was also evident from the induction of anaphase bridges and apoptosis. 18. C. Deng et al., Cell 82, 675 (1995) . 19. M. Serrano et al., ibid. 85, 27 (1996) . 20. E. H. Lee et al., Nature 359, 288 (1992) . 21. T. Jacks et al., Curr. Biol. 4, 1 (1994 ϩ T cells were isolated using a MiniMACS column and ␣CD4 beads, as described by the supplier (Milteny Biotech). Alternatively, primary human T cells were purified by a modification (www. sciencemag.org/feature/data/986472.shl) of a previously described method [D. Unutmaz, P. Pileri, S. Abrignani, J. Exp. Med. 180, 1159 (1994 ]. Resting T cells (99%) were enriched using depletion with antibodies to HLA-DR [American Type Culture Collection (ATCC)] and CD69 (Pharmingen) adsorbed onto Dynabeads (Dynal). T cells were stimulated with anti-CD3 (OKT-3; ATCC) and anti-CD28 (Pharmingen) in RPMI medium containing recombinant human interleukin-2 (200 U/ml) and 1 M Table 2 . Requirement of p53 and ATM for AdTRF2 ⌬B⌬M -induced apoptosis.
BrdU. After 12 hours, cells were infected with adenoviruses in fresh medium containing 1 M BrdU. Cells were collected onto cover slips at 24 hours after infection, fixed for 1 hour at -20°C in 70% ethanol and 50 mM glycine (pH 2.5), and processed for TUNEL labeling. Subsequently, BrdU incorporation was visualized with a Boehringer BrdU Labeling and Detection Kit #1 with a TRITC-coupled secondary antibody ( Jackson). Based on the BrdU incorporation, infection with AdTRF2 and AdTRF2 ⌬B⌬M resulted in 55% and 83% inhibition of S phase, respectively.
